With that in mind, we focus on developing lasting, well-aligned partnerships with exceptional entrepreneurs and executives to build valuable companies. In addition to capital, we provide deep healthcare domain expertise and an extensive network of industry contacts and resources.

Learn More
News
February 21, 2019 Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies
Read More
December 27, 2018 Boston Scientific Exercises Option to Acquire Millipede, Inc. for $540M (Santé Ventures Leads Deal as Only Institutional Investor)
Read More